Effectiveness of a fixed combination formula of ombitasvir/paritaprevir/ritonavir for hepatitis C virus infection in patients on maintenance haemodialysis. [electronic resource]
Producer: 20180509Description: 562-565 p. digitalISSN:- 1440-1797
- Aged
- Aged, 80 and over
- Anilides -- adverse effects
- Antiviral Agents -- adverse effects
- Carbamates -- adverse effects
- Cyclopropanes
- Disease Progression
- Drug Combinations
- Drug Compounding
- Female
- Genotype
- Hepacivirus -- drug effects
- Hepatitis C -- complications
- Humans
- Japan
- Lactams, Macrocyclic
- Liver Cirrhosis -- diagnosis
- Macrocyclic Compounds -- adverse effects
- Male
- Middle Aged
- Proline -- analogs & derivatives
- RNA, Viral -- genetics
- Renal Dialysis -- adverse effects
- Renal Insufficiency, Chronic -- complications
- Ritonavir -- adverse effects
- Sulfonamides
- Sustained Virologic Response
- Time Factors
- Treatment Outcome
- Valine
- Viral Load
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.